FindTrial
Sign In

Peripheral blood circulating DNA as a biomarker in ovarian cancer clinical research trials program

Peripheral blood circulating DNA as a biomarker in ovarian cancer clinical research trials program

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-12002966
Enrollment
Unknown
Registered
2012-12-21
Start date
2012-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

Gold Standard:
Index test:

Sponsors

the Second Affiliated Hospital of Suzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. ovarian cancer group:New-onset cases of ovarian cancer with pathological diagnosis based on.age: 20-80 years. sex: female; 2. benign ovarian cyst group: Surgical pathology confirmed cases of benign ovarian cysts. age: 20-80 years. sex: female.

Exclusion criteria

Exclusion criteria: 1. patients combined with other malignant cancer; 2. pregnancy; 3. patients combined with autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
circulating DNA;—

Countries

China

Contacts

Public ContactLi Kai
kaili34@yahoo.com+86 13776033460

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026